Zobrazeno 1 - 10
of 268
pro vyhledávání: '"Robert C. Bourge"'
Autor:
Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Dual combination therapy with a phosphodiesterase‐5 inhibitor (PDE5i) and endothelin receptor antagonist is recommended for most patients with intermediate‐risk pulmonary arterial hypertension (PAH). The RESPITE and REPLACE studies sugge
Externí odkaz:
https://doaj.org/article/9f5b66c79cd442eda20ab75c66cf4ff1
Autor:
Jeremy P. Feldman, Mardi Gomberg-Maitland, Shelley M. Shapiro, Amy A. Lautenbach, Marty Morris, Jeff A. Murphy, Aaron B. Waxman, Robert C. Bourge
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
The implanted system for treprostinil has been described in previous publications. There is no information published about how to handle this system around lung or heart–lung transplantation. We present the experience from the DelIVery for Pulmonar
Externí odkaz:
https://doaj.org/article/a1581cb080924aa99ff9d7e56d8838b8
Autor:
Niraj Varma, Robert C. Bourge, Lynne Warner Stevenson, Maria Rosa Costanzo, David Shavelle, Philip B. Adamson, Greg Ginn, John Henderson, William T. Abraham
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 5 (2021)
Background Patients with recurring heart failure (HF) following cardiac resynchronization therapy fare poorly. Their management is undecided. We tested remote hemodynamic‐guided pharmacotherapy. Methods and Results We evaluated cardiac resynchroniz
Externí odkaz:
https://doaj.org/article/324b2674bf6d42dea2f0c86dc37a5de5
Autor:
Shelley Shapiro, Robert C. Bourge, Patti Pozella, David F. Harris, Erick H. Borg, Andrew C. Nelsen
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Parenteral prostanoids are effective for improving outcomes in patients with pulmonary arterial hypertension. However, subcutaneous or intravenous delivery via an external pump places a significant burden on patients. Consequently, the Implantable Sy
Externí odkaz:
https://doaj.org/article/003d044438e34eb695c5ad4e3dcdc87f
Autor:
Mardi Gomberg-Maitland, Robert C. Bourge, Shelley M. Shapiro, James H. Tarver, Dianne L. Zwicke, Jeremy P. Feldman, Murali M. Chakinala, Robert P. Frantz, Fernando Torres, Remzi Bag, Jeffrey A. Murphy, Amy A. Lautenbach, Marty Morris, Leigh Peterson, Aaron B. Waxman
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Background The DelIVery for Pulmonary Arterial Hypertension clinical trial was a multi-center, prospective, single arm, Investigational Device Exemption study utilizing a fully implantable, programmable intravascular delivery system consisting of a p
Externí odkaz:
https://doaj.org/article/a1433a8c30ea4b7b98bec409679d6037
Autor:
J. Thomas Heywood, Sandip Zalawadiya, Robert C. Bourge, Maria Rosa Costanzo, Akshay S. Desai, Lisa D. Rathman, Nirav Raval, David M. Shavelle, John D. Henderson, Marie-Elena Brett, Philip B. Adamson, Lynne W. Stevenson
Publikováno v:
Journal of Cardiac Failure. 29:56-66
Therapy guided by pulmonary artery (PA) pressure monitoring reduces PA pressures and heart failure hospitalizations (HFH) during the first year, but the durability of efficacy and safety through 2 years is not known.The CardioMEMS Post-Approval Study
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
Parenteral prostanoids are effective for improving outcomes in patients with pulmonary arterial hypertension. However, subcutaneous or intravenous delivery via an external pump places a significant burden on patients. Consequently, the Implantable Sy
Autor:
Carmine Dario Vizza, Irene M. Lang, Roberto Badagliacca, Raymond L. Benza, Stephan Rosenkranz, R. James White, Yochai Adir, Arne K. Andreassen, Vijay Balasubramanian, Sonja Bartolome, Isabel Blanco, Robert C. Bourge, Jørn Carlsen, Rafael Enrique Conde Camacho, Michele D’Alto, Harrison W. Farber, Robert P. Frantz, H. James Ford, Stefano Ghio, Mardi Gomberg-Maitland, Marc Humbert, Robert Naeije, Stylianos E. Orfanos, Ronald J. Oudiz, Sergio V. Perrone, Oksana A. Shlobin, Marc A. Simon, Olivier Sitbon, Fernando Torres, Jean Luc Vachiery, Kuo-Yang Wang, Magdi H. Yacoub, Yan Liu, Gil Golden, Hiromi Matsubara
Publikováno v:
American journal of respiratory and critical care medicine, vol 205, iss 7
Vizza, C D, Lang, I M, Badagliacca, R, Benza, R L, Rosenkranz, S, White, R J, Adir, Y, Andreassen, A K, Balasubramanian, V, Bartolome, S, Blanco, I, Bourge, R C, Carlsen, J, Conde Camacho, R E, D'Alto, M, Farber, H W, Frantz, R P, Ford, H J, Ghio, S, Gomberg-Maitland, M, Humbert, M, Naeije, R, Orfanos, S E, Oudiz, R J, Perrone, S, Shlobin, O A, Simon, M A, Sitbon, O, Torres, F, Vachiery, J L, Wang, K-Y, Yacoub, M H, Liu, Y, Golden, G & Matsubara, H 2022, ' Aggressive Afterload Lowering to Improve the Right Ventricle A New Target for Medical Therapy in Pulmonary Arterial Hypertension? ', American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 7, pp. 751-760 . https://doi.org/10.1164/rccm.202109-2079PP
Vizza, C D, Lang, I M, Badagliacca, R, Benza, R L, Rosenkranz, S, White, R J, Adir, Y, Andreassen, A K, Balasubramanian, V, Bartolome, S, Blanco, I, Bourge, R C, Carlsen, J, Conde Camacho, R E, D'Alto, M, Farber, H W, Frantz, R P, Ford, H J, Ghio, S, Gomberg-Maitland, M, Humbert, M, Naeije, R, Orfanos, S E, Oudiz, R J, Perrone, S, Shlobin, O A, Simon, M A, Sitbon, O, Torres, F, Vachiery, J L, Wang, K-Y, Yacoub, M H, Liu, Y, Golden, G & Matsubara, H 2022, ' Aggressive Afterload Lowering to Improve the Right Ventricle A New Target for Medical Therapy in Pulmonary Arterial Hypertension? ', American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 7, pp. 751-760 . https://doi.org/10.1164/rccm.202109-2079PP
Despite numerous therapeutic advances in pulmonary arterial hypertension, patients continue to suffer high morbidity and mortality, particularly considering a median age of 50 years. This article explores whether early, robust reduction of right vent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695ce2554a81c9830cb26c2e701e488f
http://hdl.handle.net/11573/1634352
http://hdl.handle.net/11573/1634352
Autor:
Jeffrey A. Murphy, Dianne L Zwicke, Mardi Gomberg-Maitland, Amy A Lautenbach, Jeremy Feldman, Remzi Bag, Leigh Peterson, Robert P. Frantz, Aaron B. Waxman, Fernando Torres, Marty Morris, Shelley M. Shapiro, James H. Tarver, Murali M. Chakinala, Robert C. Bourge
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
Pulmonary Circulation
Pulmonary Circulation
Background The DelIVery for Pulmonary Arterial Hypertension clinical trial was a multi-center, prospective, single arm, Investigational Device Exemption study utilizing a fully implantable, programmable intravascular delivery system consisting of a p
Autor:
David M. Shavelle, Niraj Varma, John Henderson, Greg Ginn, Philip B. Adamson, Maria Rosa Costanzo, William T. Abraham, Robert C. Bourge, Lynne W. Stevenson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patients with recurring heart failure (HF) following cardiac resynchronization therapy fare poorly. Their management is undecided. We tested remote hemodynamic‐guided pharmacotherapy. Methods and Results We evaluated cardiac resynchroniz